
C. Light Technologies
Innovative eye-tracking technology for diagnosing and monitoring neurological conditions.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | Early VC | ||
Total Funding | 000k |
Related Content
C. Light Technologies specializes in advanced eye-tracking technology designed to diagnose and monitor neurological conditions such as traumatic brain injuries (TBI) and multiple sclerosis (MS). The company operates in the healthcare and medical technology market, serving healthcare providers, researchers, and clinicians. C. Light Technologies' core product, Retitrack, utilizes fixational eye motion (FEM) metrics to provide detailed insights into brain function through a 10-second video scan of the eye. This technology is FDA-cleared and leverages data science, machine learning, and artificial intelligence to deliver precise and reliable diagnostics. The business model revolves around selling and licensing its technology to medical institutions and research facilities, generating revenue through product sales, service subscriptions, and data analytics.
Keywords: eye-tracking, neurological diagnostics, traumatic brain injury, multiple sclerosis, healthcare technology, FEM metrics, Retitrack, machine learning, artificial intelligence, medical imaging.